ELI LILLY & CO is reportedly in advanced negotiations to acquire Kelonia Therapeutics for a sum exceeding $2 billion, according to a report from the Wall Street Journal on Sunday. The potential acquisition marks a significant move for the pharmaceutical giant as it continues to expand its presence in the biotechnology sector and bolster its research pipeline.
Eli Lilly in Talks to Buy Kelonia for Over $2 Billion
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion. The Wall Street Journal reported the potential deal on Sunday.
Xurve View
洞察:
Xurve View












